TMX-202

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTMX-202
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsUrinary Bladder NeoplasmsSkin NeoplasmsCondylomata Acuminata
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesTelormedix SaUniversity Of California San Diego
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsSkin NeoplasmsCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A